Back to search

Canada· CA-DIN-02224860

SOFRAMYCIN NASAL SPRAY

A phenylephrine product containing gramicidin + phenylephrine hydrochloride + framycetin sulfate, registered in Canada by SEARCHLIGHT PHARMA INC. The same ATC class is registered in 6 of our 19 countries.

ATC R01AB01

Checked against Health Canada Drug Product Database (Canada) on

Informational only — not a medical device.

SOURCE REGISTER · CAHealth Canada Drug Product Database (Ca…normalisedSOFRAMYCIN NASAL SPRAYATCR01AB01REGISTER NO.CA-DIN-02224860PACKS LISTED0CHECKEDOctober 1, 2026

Where it is registered

Phenylephrine is registered in 6 of 19 countries.

Countries holding a registration under ATC R01AB01 (phenylephrine), each read from that country’s own register.

  • This record: Canada, from Health Canada Drug Product Database (Canada)
  • 5 of them publish a price we can compare per daily dose

Phenylephrine · ATC R01AB01

6 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Finlandprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Health Canada Drug Product Database (Canada)
Active substance
GRAMICIDIN + PHENYLEPHRINE HYDROCHLORIDE + FRAMYCETIN SULFATE
Manufacturer
SEARCHLIGHT PHARMA INC
Country
Canada (CA)
ATC code
R01AB01
ATC class
Phenylephrine
Defined daily dose
0.8 ml, N
Reimbursed
Not published by this register
Source register
Health Canada Drug Product Database (Canada)
Last checked
October 1, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

58 interactions on record for phenylephrine.

Graded by severity as the source publishes them — 8 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Phenylephrine · interactions on record

58 records

  • 8 severe
  • 50 moderate

Most severe, free to view

  • MethylergometrineG02AB01severe
  • ErgometrineG02AB03severe
  • HalothaneN01AB01severe
  • DihydroergotamineN02CA01severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/897c9e5a-b296-4771-a515-d9ef7204868c
GET /v1/drugs/897c9e5a-b296-4771-a515-d9ef7204868c?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "din": "02224860",
  "form": "SPRAY",
  "class": "Human",
  "routes": [
    "NASAL"
  ],
  "source": "health_canada_dpd",
  "status": "MARKETED",
  "atc_raw": "R01AB01",
  "schedule": [
    "Prescription"
  ],
  "drug_code": "37384",
  "strengths": [
    "0.05 MG",
    "2.5 MG",
    "12.5 MG"
  ],
  "ahfs_class": null,
  "substances": [
    "GRAMICIDIN",
    "PHENYLEPHRINE HYDROCHLORIDE",
    "FRAMYCETIN SULFATE"
  ],
  "product_categorization": null
}

See everything about phenylephrine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.